Jiebing Tang

552 total citations · 1 hit paper
19 papers, 421 citations indexed

About

Jiebing Tang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiebing Tang has authored 19 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Jiebing Tang's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Jiebing Tang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Jiebing Tang collaborates with scholars based in China and Ethiopia. Jiebing Tang's co-authors include Xiaoguang Yu, Rongjun Cui, Xiulan Zheng, Yujia Pan, Dong Li, Ping Lin, Chi Liu, Ping Lin, Yanqiao Zhang and Jialin Fan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jiebing Tang

19 papers receiving 421 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial

2025 17 citations Hongwei Wang, Qun Ma et al. Nature Communications profile →

Peers

Countries citing papers authored by Jiebing Tang

Since Specialization

Citations

This map shows the geographic impact of Jiebing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiebing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiebing Tang more than expected).

Fields of papers citing papers by Jiebing Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiebing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiebing Tang. The network helps show where Jiebing Tang may publish in the future.

Co-authorship network of co-authors of Jiebing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiebing Tang. A scholar is included among the top collaborators of Jiebing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiebing Tang. Jiebing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial breakdown → 2025 ·Nature Communications ·(unknown), Hongwei Wang, Qun Ma, Kemin Jin, Ming Liu, Wei Liu, Xiaoluan Yan, Lijun Wang, Yanqiao Zhang, Guangyu Wang, Yue Ma, Zhigang Ma, Chunhui Zhang, Jiebing Tang, Sha Wang, (unknown), (unknown), Kun Wang, Bao-Cai Xing	17
2	RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis 2023 ·Acta Biochimica et Biophysica Sinica ·Chi Liu, Jie Shi, (unknown), Shan Jiang, (unknown), (unknown), Jiebing Tang, (unknown)	2
3	Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2 2023 ·Heliyon ·Ke Zhang, Chi Liu, (unknown), Ping Lin, Qi Qi, Huizhen Jia, Jiebing Tang, (unknown)	2
4	Advances and prospects of drug clinical research in colorectal cancer in 2022 2023 ·SHILAP Revista de lepidopterología ·Dan Su, Chao Liu, Jie Cui, Jiebing Tang, (unknown), Yanqiao Zhang	9
5	5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma 2020 ·Molecular Oncology ·(unknown), Wendy Wu, Chunlong Wu, Man Li, (unknown), Lu Zheng, (unknown), Xiaoling Li, (unknown), Jiebing Tang, Yang Yu, Shengnan Luo, Wenji Sun, (unknown), Cheng Qian, (unknown), Shuangxiu Wu, Tao Ji	19
6	Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation 2020 ·Journal of Molecular Endocrinology ·Yujia Pan, (unknown), (unknown), Rongjun Cui, Chi Liu, (unknown), Jialin Fan, Wenqian Jiang, Jiebing Tang, (unknown), Xiaoguang Yu, Ying Liu	9
7	LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP‐mediated pathway 2019 ·Journal of Cellular Physiology ·Changjie Lou, Juan Zhao, Yuanlong Gu, Qingwei Li, Shuli Tang, (unknown), Jiebing Tang, Chunhui Zhang, Zhiwei Li, Yanqiao Zhang	46
8	miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma 2019 ·Cancer Medicine ·Rongjun Cui, Jialin Fan, (unknown), Yujia Pan, Chi Liu, (unknown), Wei Wang, (unknown), Xiulan Zheng, Jiebing Tang, Xiaoguang Yu	27
9	Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma 2018 ·Cellular Physiology and Biochemistry ·Yujia Pan, (unknown), Rongjun Cui, Jialin Fan, Chi Liu, (unknown), Jiebing Tang, Hui Xie, Ping Lin, (unknown), Xiaoguang Yu	44
10	OCT4B modulates OCT4A expression as ceRNA in tumor cells 2015 ·Oncology Reports ·Dong Li, (unknown), (unknown), Chunyan Xu, Hui Sun, Jiebing Tang, Ping Lin, Wen‐Chih Cheng, Ning Huang, Rongjun Cui, Xiaoguang Yu, (unknown)	29
11	Calcium Ion Flow Permeates Cells through SOCs to Promote Cathode-Directed Galvanotaxis 2015 ·PLoS ONE ·Liang Guo, (unknown), Dong Li, (unknown), Jiebing Tang, (unknown), Hui Sun, (unknown), Wenjing Sun, Xiaoguang Yu	23
12	Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition 2015 ·Molecular Medicine Reports ·Jiebing Tang, Yuanyuan Chen, Rongjun Cui, Dong Li, (unknown), Ping Lin, (unknown), (unknown), Xiaoguang Yu, Xiulan Zheng	26
13	CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells 2015 ·Oncology Reports ·Jiebing Tang, (unknown), Rongjun Cui, Dong Li, Xiulan Zheng, Lijuan Zhu, (unknown), Yujia Pan, (unknown), Xiaoguang Yu	39
14	MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells 2014 ·International Journal of Oncology ·Wei Qin, Yujia Pan, Xiulan Zheng, (unknown), (unknown), Chunyan Xu, Jiebing Tang, Rongjun Cui, Ping Lin, Xiaoguang Yu	31
15	ETV1 induces epithelial to mesenchymal transition in human gastric cancer cells through the upregulation of Snail expression 2013 ·Oncology Reports ·Zhiwei Li, Libin Zhang, Zhigang Ma, Ming Yang, Jiebing Tang, (unknown), (unknown), Xuan Hong, Yanqiao Zhang	24
16	DNA methylation inhibitor, decitabine, promotes MGC803 gastric cancer cell migration and invasion via the upregulation of NEDD4-1 2012 ·Molecular Medicine Reports ·Dong Li, Chunyan Xu, Rongjun Cui, Jiebing Tang, Hui Sun, (unknown), (unknown), Ping Lin, Ning Huang, (unknown), Xiaoguang Yu	10
17	Hypoxia increases CX3CR1 expression via HIF-1 and NF-κB in androgen-independent prostate cancer cells 2012 ·International Journal of Oncology ·(unknown), Yuanyuan Chen, Ping Lin, Haifeng Zou, Feng Lin, Linan Zhao, Dong Li, Liang Guo, Jiebing Tang, Xiulan Zheng, Xiaoguang Yu	33
18	Involvement of the calcium-sensing receptor in cyclosporin A-induced cardiomyocyte apoptosis in rats. 2011 ·PubMed ·Yanru Zhao, (unknown), Yuquan Zhang, Jinyu Chi, Lingling Zhang, (unknown), Jiebing Tang, Yue Liu, (unknown), Xinhua Yin	9
19	Cyclosporin A induces cardiomyocyte injury through calcium-sensing receptor-mediated calcium overload. 2011 ·PubMed ·Jiebing Tang, (unknown), Yue Liu, Yu Fu, Jinyu Chi, Yejing Zhu, Yanru Zhao, Xinhua Yin	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact